Prospects for the treatment of autoimmune diabetes.

Abstract

Autoimmune Type 1 Diabetes (T1D) is a chronic endocrine disorder that arises due to autoimmune destruction of pancreatic beta cells. With the global rise in incidence and challenges in disease management, the relevance of innovative treatment methods for T1D is continually increasing. The aim of the study. To analyze current trends and prospects in the treatment of autoimmune diabetes, including immunomodulatory therapy, cellular technologies, artificial insulin regulation systems, gene therapy, and individualized treatment approaches, based on a comprehensive review of literature data.